Texas Instruments enters the week of June 9 with a striking disconnect: analysts are lifting price targets at a pace rarely seen for this stock, yet insiders have been selling consistently — and the share price has given back 6.3% in five trading days.
The analyst picture is unusually bullish. Wells Fargo raised its target to $300 from $260 on June 9, keeping an Equal-Weight rating. B of A Securities moved its target to $370 from $320 in late May. Seaport Global upgraded outright to Buy with a $400 target on May 22. The direction of travel is clear: targets have been moving sharply higher since the April earnings beat, with multiple firms lifting by $40–$70 in a single revision. The mean target now sits at $290, roughly in line with the current price of $288.63. That convergence tells its own story — the Street sees fair value near here, not a screaming discount. Bulls point to TXN's positioning in analog chips for AI-driven data centers and the structural tailwinds from high-performance computing demand. Bears remain focused on elevated inventory levels, ongoing pressure in automotive markets, and the risk that a broader macro slowdown trims near-term revenue growth.
Positioning in the lending market offers almost no signal either way — this is one of the most freely available large-cap names to borrow. Availability is effectively unlimited, running at the ceiling of the ORTEX scale, meaning shorts face no constraint at all in adding exposure. Cost to borrow has more than halved in the past month to just 0.21%, the lowest level in the 30-day window, down from above 0.55% in mid-May. Short interest itself has climbed 18% over the past month to 2.1% of the free float — worth noting, but not alarming at this absolute level. Options traders are barely defensive: the put/call ratio at 0.86 is a touch below its 20-day average of 0.89, a half-standard-deviation tilt toward calls. Nothing in the lending or options market looks like a crowded short.
The insider picture is where the note gets more interesting. CFO Rafael Lizardi sold just over 47,700 shares across three transactions on May 14, collecting roughly $14.3 million. A senior vice president sold in both May 11 and May 5. An independent director sold nearly $3.2 million of stock on May 28. The 90-day net across all insiders is a positive 277,068 shares, but that figure is distorted by option-related flows — the raw recent trade log is a clean sweep of sells by named officers and directors. None of these transactions carry high significance scores, suggesting they are largely plan-driven rather than opportunistic, but the cluster of sales into post-earnings strength is worth registering.
TXN's most recent earnings print was the sharpest reaction in years. The April 22 Q1 release drove a 21% single-day gain and a 15.5% five-day move — a far more dramatic response than the sector-wide inventory-normalisation narrative would imply. An analyst day or interim event on April 16 produced a 6.3% one-day move and a remarkable 30.5% five-day follow-through. The next scheduled print is July 20, and the bar will be meaningfully higher given how sharply the stock re-rated in April. Analog peers have broadly sold off this week — ON Semiconductor fell 9%, NXP Semiconductors lost 8%, and Synaptics dropped more than 10% — making TXN's 6.3% decline look relatively contained given where it sits in that cohort.
With analyst targets clustered just above the current price, insiders having sold into the April rally, and a July 20 earnings date approaching, the debate from here is whether TXN's Q2 guidance can justify the re-rating the Street has already awarded it.
See the live data behind this article on ORTEX.
Open TXN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
